Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Paul Bunn to Carcinoma, Small Cell

This is a "connection" page, showing publications Paul Bunn has written about Carcinoma, Small Cell.

 
Connection Strength
  
 
 
5.133
  
  1. Bunn PA. Diseases desperate grown. J Natl Cancer Inst. 2008 Apr 16; 100(8):520-1.
    View in: PubMed
    Score: 0.290
  2. Bunn PA. The potential role of proteasome inhibitors in the treatment of lung cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4263s-4265s.
    View in: PubMed
    Score: 0.223
  3. Bunn PA, Shepherd FA, Sandler A, Le Chevalier T, Belani CP, Kosmidis PA, Scagliotti GV, Giaccone G. Ongoing and future trials of biologic therapies in lung cancer. Lung Cancer. 2003 Aug; 41 Suppl 1:S175-86.
    View in: PubMed
    Score: 0.210
  4. Bunn PA, Soriano A, Johnson G, Heasley L. New therapeutic strategies for lung cancer: biology and molecular biology come of age. Chest. 2000 Apr; 117(4 Suppl 1):163S-168S.
    View in: PubMed
    Score: 0.167
  5. Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer. Clin Cancer Res. 1999 Nov; 5(11):3419-24.
    View in: PubMed
    Score: 0.162
  6. Bunn PA, Kelly K. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-144-S12-148.
    View in: PubMed
    Score: 0.138
  7. Bunn PA. The emerging role of gemcitabine in lung cancer: part I. Semin Oncol. 1997 Apr; 24(2 Suppl 7):S7-1.
    View in: PubMed
    Score: 0.135
  8. Bunn PA, Carney DN. Overview of chemotherapy for small cell lung cancer. Semin Oncol. 1997 Apr; 24(2 Suppl 7):S7-69-S7-74.
    View in: PubMed
    Score: 0.135
  9. Bunn PA. Combination paclitaxel and platinum in the treatment of lung cancer: US experience. Semin Oncol. 1996 Dec; 23(6 Suppl 15):9-15.
    View in: PubMed
    Score: 0.132
  10. Bunn PA. Current therapy of small cell lung cancer. Semin Oncol. 1996 Dec; 23(6 Suppl 16):1-4.
    View in: PubMed
    Score: 0.132
  11. Bunn PA, Kelly K. Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study. Semin Oncol. 1996 Dec; 23(6 Suppl 16):11-5.
    View in: PubMed
    Score: 0.132
  12. Bunn PA. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Semin Oncol. 1996 Dec; 23(6 Suppl 16):18-25.
    View in: PubMed
    Score: 0.132
  13. Bunn PA, Kelly KL. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study. Semin Oncol. 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60.
    View in: PubMed
    Score: 0.122
  14. Bunn PA, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR, et al. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol. 1995 Jul; 13(7):1632-41.
    View in: PubMed
    Score: 0.120
  15. Bunn PA, Kelly K. New treatment agents for advanced small cell and non-small cell lung cancer. Semin Oncol. 1995 Jun; 22(3 Suppl 6):53-63.
    View in: PubMed
    Score: 0.119
  16. Bunn PA, Kelly K. Prophylactic cranial irradiation for patients with small-cell lung cancer. J Natl Cancer Inst. 1995 Feb 01; 87(3):161-2.
    View in: PubMed
    Score: 0.116
  17. Bunn PA, Chan D, Stewart J, Gera L, Tolley R, Jewett P, Tagawa M, Alford C, Mochzuki T, Yanaihara N. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines. Cancer Res. 1994 Jul 01; 54(13):3602-10.
    View in: PubMed
    Score: 0.112
  18. Bunn P, Arriagada R, Choi N, Feld R, Gregor A, Jett J, Johnson B, Komaki R, Kristjansen P, Murray N, et al. Combined modality therapy in small cell lung cancer. Lung Cancer. 1994 Mar; 10 Suppl 1:S25-8.
    View in: PubMed
    Score: 0.109
  19. Bunn PA, Van Zandwijk N, Pastorino U, Aisner J, Alberto P, Arriagada R, Carney D, Cornis R, Dittrich C, Gatzemeier U, et al. European School of Oncology. First Euro-American Forum on Lung Cancer Treatment. Eur J Cancer. 1994; 30A(5):710-3.
    View in: PubMed
    Score: 0.108
  20. Bunn PA, Kelly K. The role of routine chest radiotherapy in small-cell lung cancer. An issue of timing and stage. Chest. 1993 Sep; 104(3):661-2.
    View in: PubMed
    Score: 0.106
  21. Cook RM, Miller YE, Bunn PA. Small cell lung cancer: etiology, biology, clinical features, staging, and treatment. Curr Probl Cancer. 1993 Mar-Apr; 17(2):69-141.
    View in: PubMed
    Score: 0.102
  22. Bunn PA, Chan D, Dienhart DG, Tolley R, Tagawa M, Jewett PB. Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity. Cancer Res. 1992 Jan 01; 52(1):24-31.
    View in: PubMed
    Score: 0.094
  23. Kelly K, Kane MA, Bunn PA. Growth factors in lung cancer: possible etiologic role and clinical target. Med Pediatr Oncol. 1991; 19(6):450-8.
    View in: PubMed
    Score: 0.088
  24. Bunn PA. Operation for stage IIIa small cell lung cancer? Ann Thorac Surg. 1990 May; 49(5):691.
    View in: PubMed
    Score: 0.084
  25. Beck LK, Kane MA, Bunn PA. Innovative and future approaches to small cell lung cancer treatment. Semin Oncol. 1988 Jun; 15(3):300-14.
    View in: PubMed
    Score: 0.073
  26. Byers T, Wolf HJ, Franklin WA, Braudrick S, Merrick DT, Shroyer KR, Hirsch FR, Zeng C, Bar?n AE, Bunn PA, Miller YE, Kennedy TC. Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity. Cancer Epidemiol Biomarkers Prev. 2008 Jan; 17(1):158-62.
    View in: PubMed
    Score: 0.071
  27. Bunn PA, Lichter AS, Makuch RW, Cohen MH, Veach SR, Matthews MJ, Anderson AJ, Edison M, Glatstein E, Minna JD, et al. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med. 1987 May; 106(5):655-62.
    View in: PubMed
    Score: 0.068
  28. Bunn PA, Greco FA, Einhorn L. Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer. Semin Oncol. 1986 Sep; 13(3 Suppl 3):45-53.
    View in: PubMed
    Score: 0.065
  29. Sunpaweravong P, Magree L, Rabinovitch R, Bunn P, Kelly K. A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer. Invest New Drugs. 2006 May; 24(3):213-21.
    View in: PubMed
    Score: 0.063
  30. Hanna N, Bunn PA, Langer C, Einhorn L, Guthrie T, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol. 2006 May 01; 24(13):2038-43.
    View in: PubMed
    Score: 0.063
  31. Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunn P, et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med. 1985 May 01; 161(5):1135-51.
    View in: PubMed
    Score: 0.059
  32. Bunn PA, Linnoila I, Minna JD, Carney D, Gazdar AF. Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. Blood. 1985 Mar; 65(3):764-8.
    View in: PubMed
    Score: 0.059
  33. Lynch TJ, Adjei AA, Bunn PA, DuBois RN, Gandara DR, Giaccone G, Govindan R, Herbst RS, Johnson BE, Khuri FR, Perez-Soler R, Rosell R, Rowinsky EK, Sandler AB, Scagliotti GV, Schiller JH, Shapiro GI, Socinski MA, Hart CS. Novel agents in the treatment of lung cancer: conference summary statement. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4199s-4204s.
    View in: PubMed
    Score: 0.056
  34. Rosen ST, Makuch RW, Lichter AS, Ihde DC, Matthews MJ, Minna JD, Glatstein E, Bunn PA. Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response. Am J Med. 1983 Apr; 74(4):615-24.
    View in: PubMed
    Score: 0.051
  35. Batist G, Ihde DC, Zabell A, Lichter AS, Veach SR, Cohen MH, Carney DN, Bunn PA. Small-cell carcinoma of lung: reinduction therapy after late relapse. Ann Intern Med. 1983 Apr; 98(4):472-4.
    View in: PubMed
    Score: 0.051
  36. Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM, Bunn PA. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin Cancer Res. 2002 May; 8(5):1280-7.
    View in: PubMed
    Score: 0.048
  37. Rosen ST, Aisner J, Makuch RW, Matthews MJ, Ihde DC, Whitacre M, Glatstein EJ, Wiernik PH, Lichter AS, Bunn PA. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore). 1982 Jan; 61(1):45-53.
    View in: PubMed
    Score: 0.047
  38. Bunn PA. Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'. Ann Oncol. 2001 Oct; 12(10):1339-40.
    View in: PubMed
    Score: 0.046
  39. Bunn PA, Helfrich BA, Brenner DG, Chan DC, Dykes DJ, Cohen AJ, Miller YE. Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. Clin Cancer Res. 1998 Nov; 4(11):2849-58.
    View in: PubMed
    Score: 0.038
  40. Bunn PA, Nugent JL, Matthews MJ. Central nervous system metastases in small cell bronchogenic carcinoma. Semin Oncol. 1978 Sep; 5(3):314-22.
    View in: PubMed
    Score: 0.037
  41. Beekman A, Helfrich B, Bunn PA, Heasley LE. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth. Cancer Res. 1998 Mar 01; 58(5):910-3.
    View in: PubMed
    Score: 0.036
  42. Bunn PA. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-153-S12-162.
    View in: PubMed
    Score: 0.035
  43. Cohen AJ, Skidgel RA, Gilman LB, Black JK, Bunn PA, Helfrich B, Franklin WA, Miller YE. Carboxypeptidase M. Variable expression in normal human lung and inactivation in lung cancer. Chest. 1997 Jun; 111(6 Suppl):149S.
    View in: PubMed
    Score: 0.034
  44. Bunn PA, Kelly K. Systemic investigational therapies as adjuvants to surgery in patients with operable lung cancer. Semin Oncol. 1997 Jun; 24(3 Suppl 8):S8-46-S8-52.
    View in: PubMed
    Score: 0.034
  45. Bunn PA, Cohen MH, Ihde DC, Fossieck BE, Matthews MJ, Minna JD. Advances in small cell bronchogenic carcinoma. Cancer Treat Rep. 1977 May-Jun; 61(3):333-42.
    View in: PubMed
    Score: 0.034
  46. Chan D, Gera L, Helfrich B, Helm K, Stewart J, Whalley E, Bunn P. Novel bradykinin antagonist dimers for the treatment of human lung cancers. Immunopharmacology. 1996 Jun; 33(1-3):201-4.
    View in: PubMed
    Score: 0.032
  47. Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cancer Res. 1996 Feb 15; 56(4):831-9.
    View in: PubMed
    Score: 0.031
  48. Heasley LE, Zamarripa J, Storey B, Helfrich B, Mitchell FM, Bunn PA, Johnson GL. Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase-deficient G alpha 16. J Biol Chem. 1996 Jan 05; 271(1):349-54.
    View in: PubMed
    Score: 0.031
  49. Kelly K, Crowley JJ, Bunn PA, Hazuka MB, Beasley K, Upchurch C, Weiss GR, Hicks WJ, Gandara DR, Rivkin S, et al. Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study. J Clin Oncol. 1995 Dec; 13(12):2924-30.
    View in: PubMed
    Score: 0.031
  50. Franklin WA, Waintrub M, Edwards D, Christensen K, Prendegrast P, Woods J, Bunn PA, Kolhouse JF. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Cancer Suppl. 1994; 8:89-95.
    View in: PubMed
    Score: 0.027
  51. Bunn PA. Clinical experiences with carboplatin (paraplatin) in lung cancer. Semin Oncol. 1992 Feb; 19(1 Suppl 2):1-11.
    View in: PubMed
    Score: 0.024
  52. Bunn PA, Dienhart DG, Chan D, Puck TT, Tagawa M, Jewett PB, Braunschweiger E. Neuropeptide stimulation of calcium flux in human lung cancer cells: delineation of alternative pathways. Proc Natl Acad Sci U S A. 1990 Mar; 87(6):2162-6.
    View in: PubMed
    Score: 0.021
  53. Bunn PA. Review of therapeutic trials of carboplatin in lung cancer. Semin Oncol. 1989 Apr; 16(2 Suppl 5):27-33.
    View in: PubMed
    Score: 0.019
  54. Carmichael J, Crane JM, Bunn PA, Glatstein E, Ihde DC. Results of therapeutic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys. 1988 Mar; 14(3):455-9.
    View in: PubMed
    Score: 0.018
  55. Doyle LA, Cuttitta F, Mulshine JL, Bunn PA, Minna JD. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells. Cancer Res. 1987 Oct 01; 47(19):5009-13.
    View in: PubMed
    Score: 0.018
  56. Pedersen AG, Becker KL, Bach F, Snider RH, Gazdar AF, Sorensen PS, Bunn PA, Hansen HH. Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer. J Clin Oncol. 1986 Nov; 4(11):1620-7.
    View in: PubMed
    Score: 0.016
  57. Ihde DC, Deisseroth AB, Lichter AS, Bunn PA, Carney DN, Cohen MH, Veach SR, Makuch RW, Johnston-Early A, Abrams RA, et al. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct; 4(10):1443-54.
    View in: PubMed
    Score: 0.016
  58. Batist G, Carney DN, Cowan KH, Veach SR, Gilliom M, Bunn PA, Ihde DC. Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates. J Clin Oncol. 1986 Jun; 4(6):982-6.
    View in: PubMed
    Score: 0.016
  59. Johnson BE, Ihde DC, Matthews MJ, Bunn PA, Zabell A, Makuch RW, Johnston-Early A, Cohen MH, Glatstein E, Minna JD. Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer. Am J Med. 1986 Jun; 80(6):1103-10.
    View in: PubMed
    Score: 0.016
  60. Fargion S, Carney D, Mulshine J, Rosen S, Bunn P, Jewett P, Cuttitta F, Gazdar A, Minna J. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res. 1986 May; 46(5):2633-8.
    View in: PubMed
    Score: 0.016
  61. Brooks BJ, Seifter EJ, Walsh TE, Lichter AS, Bunn PA, Zabell A, Johnston-Early A, Edison M, Makuch RW, Cohen MH, et al. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol. 1986 Feb; 4(2):200-9.
    View in: PubMed
    Score: 0.016
  62. Johnson BE, Ihde DC, Bunn PA, Becker B, Walsh T, Weinstein ZR, Matthews MJ, Whang-Peng J, Makuch RW, Johnston-Early A, et al. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. Ann Intern Med. 1985 Sep; 103(3):430-8.
    View in: PubMed
    Score: 0.015
  63. Gazdar AF, Bunn PA, Minna JD, Baylin SB. Origin of human small cell lung cancer. Science. 1985 Aug 16; 229(4714):679-80.
    View in: PubMed
    Score: 0.015
  64. Lichter AS, Bunn PA, Ihde DC, Cohen MH, Makuch RW, Carney DN, Johnston-Early A, Minna JD, Glatstein E. The role of radiation therapy in the treatment of small cell lung cancer. Cancer. 1985 May 01; 55(9 Suppl):2163-75.
    View in: PubMed
    Score: 0.015
  65. Morstyn G, Ihde DC, Lichter AS, Bunn PA, Carney DN, Glatstein E, Minna JD. Small cell lung cancer 1973-1983: early progress and recent obstacles. Int J Radiat Oncol Biol Phys. 1984 Apr; 10(4):515-39.
    View in: PubMed
    Score: 0.014
  66. Brower M, Ihde DC, Johnston-Early A, Bunn PA, Cohen MH, Carney DN, Makuch RW, Matthews MJ, Radice PA, Minna JD. Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy. Am J Med. 1983 Dec; 75(6):993-1000.
    View in: PubMed
    Score: 0.013
  67. Johnston-Early A, Cohen MH, Fossieck BE, Harwood S, Ihde DC, Bunn PA, Matthews MJ, Minna JD, Makuch R. Delayed hypersensitivity skin testing as a prognostic indicator in patients with small cell lung cancer. Cancer. 1983 Oct 15; 52(8):1395-400.
    View in: PubMed
    Score: 0.013
  68. Bleehen NM, Bunn PA, Cox JD, Dombernowsky P, Fox RM, H?st H, Joss R, White JE, Wittes RE. Role of radiation therapy in small cell anaplastic carcinoma of the lung. Cancer Treat Rep. 1983 Jan; 67(1):11-9.
    View in: PubMed
    Score: 0.013
  69. Radice PA, Matthews MJ, Ihde DC, Gazdar AF, Carney DN, Bunn PA, Cohen MH, Fossieck BE, Makuch RW, Minna JD. The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer. 1982 Dec 15; 50(12):2894-902.
    View in: PubMed
    Score: 0.013
  70. Whang-Peng J, Bunn PA, Kao-Shan CS, Lee EC, Carney DN, Gazdar A, Minna JD. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet. 1982 Jun; 6(2):119-34.
    View in: PubMed
    Score: 0.012
  71. Ihde DC, Johnston-Early A, Carney DN, Cohen MH, Bunn PA, Pelsor FR, Minna JD. Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep. 1982 May; 66(5):1223-5.
    View in: PubMed
    Score: 0.012
  72. Stewart JM, Gera L, Chan DC, Bunn PA, York EJ, Simkeviciene V, Helfrich B. Bradykinin-related compounds as new drugs for cancer and inflammation. Can J Physiol Pharmacol. 2002 Apr; 80(4):275-80.
    View in: PubMed
    Score: 0.012
  73. Ihde DC, Dunnick NR, Johnston-Early A, Bunn PA, Cohen MH, Minna JD. Abdominal computed tomography in small cell lung cancer: assessment of extent of disease and response to therapy. Cancer. 1982 Apr 01; 49(7):1485-90.
    View in: PubMed
    Score: 0.012
  74. Carney DN, Marangos PJ, Ihde DC, Bunn PA, Cohen MH, Minna JD, Gazdar AF. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet. 1982 Mar 13; 1(8272):583-5.
    View in: PubMed
    Score: 0.012
  75. Thant M, Hawley RJ, Smith MT, Cohen MH, Minna JD, Bunn PA, Ihde DC, West W, Matthews MJ. Possible enhancement of vincristine neuropathy by VP-16. Cancer. 1982 Mar 01; 49(5):859-64.
    View in: PubMed
    Score: 0.012
  76. Bradley EC, Schechter GP, Matthews MJ, Whang-Peng J, Cohen MH, Bunn PA, Ihde DC, Minna JD. Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer. Cancer. 1982 Jan 15; 49(2):221-3.
    View in: PubMed
    Score: 0.012
  77. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science. 1982 Jan 08; 215(4529):181-2.
    View in: PubMed
    Score: 0.012
  78. Minna JD, Bunn PA, Carney DN, Cohen MH, Cuttita F, Fosieck BE, Gazdar AF, Ihde DC, Johnston-Early A, Matthews MJ, Makuch R, Oie H, Rosen S, Lichter A, Glatstein E. Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer. Bull Cancer. 1982; 69(1):83-93.
    View in: PubMed
    Score: 0.012
  79. Carney DN, Gazdar AF, Bunn PA, Guccion JG. Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. Stem Cells (1981). 1982; 1(3):149-64.
    View in: PubMed
    Score: 0.012
  80. Minna JD, Cuttitta F, Rosen S, Bunn PA, Carney DN, Gazdar AF, Krasnow S. Methods for production of monoclonal antibodies with specificity for human lung cancer cells. In Vitro. 1981 Dec; 17(12):1058-70.
    View in: PubMed
    Score: 0.012
  81. Earle MF, Fossieck BE, Cohen MH, Ihde DC, Bunn PA, Minna JD. Perirectal infections in patients with small cell lung cancer. JAMA. 1981 Nov 27; 246(21):2464-6.
    View in: PubMed
    Score: 0.012
  82. Levenson RM, Ihde DC, Huberman MS, Cohen MH, Bunn PA, Minna JD. Phase II trial of cisplatin in small cell carcinoma of the lung. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):905-7.
    View in: PubMed
    Score: 0.011
  83. Levenson RM, Ihde DC, Matthews MJ, Cohen MH, Gazdar AF, Bunn PA, Minna JD. Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy. J Natl Cancer Inst. 1981 Sep; 67(3):607-12.
    View in: PubMed
    Score: 0.011
  84. Levenson RM, Sauerbrunn BJ, Ihde DC, Bunn PA, Cohen MH, Minna JD. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response. AJR Am J Roentgenol. 1981 Jul; 137(1):31-5.
    View in: PubMed
    Score: 0.011
  85. Carney DN, Bunn PA, Gazdar AF, Pagan JA, Minna JD. Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci U S A. 1981 May; 78(5):3185-9.
    View in: PubMed
    Score: 0.011
  86. Cohen MH, Makuch R, Johnston-Early A, Ihde DC, Bunn PA, Fossieck BE, Minna JD. Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep. 1981 Mar-Apr; 65(3-4):187-95.
    View in: PubMed
    Score: 0.011
  87. Carney DN, Matthews MJ, Ihde DC, Bunn PA, Cohen MH, Makuch RW, Gazdar AF, Minna JD. Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival. J Natl Cancer Inst. 1980 Dec; 65(6):1225-30.
    View in: PubMed
    Score: 0.011
  88. Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE, Ihde DC, Bunn PA, Matthews MJ, Makuch R. Smoking abstinence and small cell lung cancer survival. An association. JAMA. 1980 Nov 14; 244(19):2175-9.
    View in: PubMed
    Score: 0.011
  89. Gazdar AF, Carney DN, Russell EK, Sims HL, Baylin SB, Bunn PA, Guccion JG, Minna JD. Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res. 1980 Oct; 40(10):3502-7.
    View in: PubMed
    Score: 0.011
  90. Huberman M, Fossieck BE, Bunn PA, Cohen MH, Ihde DC, Minna JD. Herpes zoster and small cell bronchogenic carcinoma. Am J Med. 1980 Feb; 68(2):214-8.
    View in: PubMed
    Score: 0.010
  91. Nugent JL, Bunn PA, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer. 1979 Nov; 44(5):1885-93.
    View in: PubMed
    Score: 0.010
  92. Ihde DC, Bilek FS, Cohen MH, Bunn PA, Eddy J, Minna JD. Response to thoracic radiotherapy in patients with small cell carcinoma of the lung after failure of combination chemotherapy. Radiology. 1979 Aug; 132(2):443-6.
    View in: PubMed
    Score: 0.010
  93. Cohen MH, Chretien PB, Ihde DC, Fossieck BE, Makuch R, Bunn PA, Johnston AV, Shackney SE, Matthews MJ, Lipson SD, Kenady DE, Minna JD. Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer. JAMA. 1979 Apr 27; 241(17):1813-5.
    View in: PubMed
    Score: 0.010
  94. Ihde DC, Simms EB, Matthews MJ, Cohen MH, Bunn PA, Minna JD. Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis. Blood. 1979 Apr; 53(4):677-86.
    View in: PubMed
    Score: 0.010
  95. Cohen MH, Ihde DC, Bunn PA, Fossieck BE, Matthews MJ, Shackney SE, Johnston-Early A, Makuch R, Minna JD. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep. 1979 Feb; 63(2):163-70.
    View in: PubMed
    Score: 0.010
  96. Brigham BA, Bunn PA, Minna JD, Cohen MH, Ihde DC, Shackney SE. Growth rates of small cell bronchogenic carcinomas. Cancer. 1978 Dec; 42(6):2880-6.
    View in: PubMed
    Score: 0.009
  97. Ihde DC, Cohen MH, Bernath AM, Matthews MJ, Bunn PA, Minna JD. Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung: early detection of patients at high risk of relapse. Chest. 1978 Nov; 74(5):531-6.
    View in: PubMed
    Score: 0.009
  98. Cohen MH, Bunn PA, Ihde DC, Fossieck BE, Minna JD. Chemotherapy rather than demeclocycline for inappropriate secretion of antidiuretic hormone. N Engl J Med. 1978 Jun 22; 298(25):1423-4.
    View in: PubMed
    Score: 0.009
  99. Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl. Cancer Res. 1992 Sep 01; 52(17):4752-7.
    View in: PubMed
    Score: 0.006
  100. Funa K, Dawson N, Jewett PB, Agren H, Ruckdeschel JC, Bunn PA, Gazdar AF. Automated fluorescent analysis for drug-induced cytotoxicity assays. Cancer Treat Rep. 1986 Oct; 70(10):1147-51.
    View in: PubMed
    Score: 0.004
  101. Ihde DC, Makuch RW, Carney DN, Bunn PA, Cohen MH, Matthews MJ, Minna JD. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis. 1981 May; 123(5):500-7.
    View in: PubMed
    Score: 0.003
  102. Ihde DC, Cohen MH, Simms EB, Matthews MJ, Bunn PA, Minna JD. Evaluation of response to chemotherapy with fiberoptic bronchoscopy in non-small cell lung cancer. Cancer. 1980 Apr 01; 45(7):1693-6.
    View in: PubMed
    Score: 0.003
  103. Radice PA, Bunn PA, Ihde DC. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies. Cancer Treat Rep. 1979 Aug; 63(8):1231-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)